[
    [
        {
            "time": "2023-10-01",
            "original_text": "Dividend Aristocrats For Safe Dividends And High Total Returns",
            "features": {
                "keywords": [
                    "Dividend Aristocrats",
                    "Safe Dividends",
                    "High Total Returns"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "stocks"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Dividend Aristocrats For Safe Dividends And High Total Returns",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "How is Abbvie Inc (NYSE: ABBV) Preparing For Life After Humira?",
            "features": {
                "keywords": [
                    "Abbvie Inc",
                    "Humira",
                    "Preparing"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "How is Abbvie Inc (NYSE: ABBV) Preparing For Life After Humira?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Only these five dividend stocks made the cut in a ‘safer and better’ screen",
            "features": {
                "keywords": [
                    "dividend stocks",
                    "safer and better",
                    "made the cut"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "stocks"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Only these five dividend stocks made the cut in a ‘safer and better’ screen",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 4,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]